Latest Operational Costs News

Savannah Goldfields has resumed gold production at its Georgetown plant with strong sales and exploration results, backed by a $15 million capital raise to fuel growth and new project development.

AVADA Group Limited reported a robust 24% increase in cash receipts for Q2 FY26, driven by strong sales and strategic leadership changes, while expanding its trade finance facility to support ongoing growth.

McLaren Minerals has completed a pivotal Pre-Feasibility Study for its McLaren Titanium Project, confirming a large-scale resource and robust economics, while also acquiring a zircon-rich asset to diversify its portfolio.

Halo Technologies reports a strategic pivot under new CEO Peter Oxlade, adopting a capital-light B2B model in the UK and expanding its Australian managed funds offering, while maintaining stable subscription revenue despite seasonal headwinds.

Stavely Minerals has initiated an updated 2026 Scoping Study for its Stavely Project, reflecting significantly improved metal prices and exploration results that extend gold mineralisation across multiple prospects.

Xstate Resources has reported a promising gas discovery at its Diona-1 well in Queensland, updating prospective resources to 200 billion cubic feet and securing funding for upcoming appraisal and production testing.

Thrive Tribe Technologies reported a $186,000 net operating cash outflow in Q2 FY26, offset by a $300,000 equity raise to fund growth initiatives and operational expansion.

333D Ltd reports continued revenue growth in digital asset management and unveils a pioneering blockchain solution for MRI data storage, reinforcing its foothold in digital healthcare.

Admiralty Resources reported a $3.1 million cash outflow for the December quarter, with less than one quarter of funding available. Despite this, the company expects to maintain operations supported by iron ore sales and a significant prepayment.

Gibb River Diamonds has progressed mining operations at its Edjudina Gold Project with ore processing underway and first cash proceeds expected early this year. Despite a pit wall incident, operations resumed smoothly under a joint venture with BML Ventures.

Vectus Biosystems is close to finalising a $4.3 million transaction with Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its anti-fibrotic drug candidates amid cost reductions.

Australis Oil & Gas reported steady production in Q4 2025 despite lower oil prices, completing key transactions that bolster its financial position and development prospects in the Tuscaloosa Marine Shale.